Aromatase inhibitors, bisphosphonates cut postmenopausal breast cancer recurrence

Aromatase inhibitors and bisphosphonates can improve survival in postmenopausal early-stage breast cancer, and combining the two drug classes can help negate their individual adverse effects,...